Invention Grant
US09221878B2 Cyclosporin analogues for preventing or treating hepatitis C infection
有权
用于预防或治疗丙型肝炎感染的环孢菌素类似物
- Patent Title: Cyclosporin analogues for preventing or treating hepatitis C infection
- Patent Title (中): 用于预防或治疗丙型肝炎感染的环孢菌素类似物
-
Application No.: US14469403Application Date: 2014-08-26
-
Publication No.: US09221878B2Publication Date: 2015-12-29
- Inventor: Yat Sun Or , Guoqiang Wang , Jiang Long , In Jong Kim
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore, Esq.
- Main IPC: C07K7/64
- IPC: C07K7/64 ; A61K38/13 ; A61K45/06 ; A61K38/21 ; A61K38/00
Abstract:
The present invention relates to novel cyclosporine analogs having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporine analog compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.
Public/Granted literature
- US20150056165A1 NOVEL CYCLOSPORIN ANALOGUES FOR PREVENTING OR TREATING HEPATITIS C INFECTION Public/Granted day:2015-02-26
Information query
